CN Stock MarketDetailed Quotes

300573 Shenyang Xingqi Pharmaceutical

Watchlist
  • 259.48
  • -0.10-0.04%
Noon Break May 6 11:30 CST
32.33BMarket Cap126.58P/E (TTM)

About Shenyang Xingqi Pharmaceutical Company

The company is a national high-tech enterprise specializing in R&D, production and sales of ophthalmic drugs. On December 8, 2016, the company was listed on the Shenzhen Stock Exchange GEM. It won the 9th Liaoning Provincial Governor's Quality Silver Award in 2022 and the 20th National Quality Award in 2023. The company leads the high-quality development of enterprises with high-quality party building, adheres to the mission of “managing health and creating light”, implements the values of “persistence, innovation, responsibility and win-win” with the vision of “becoming a globally competitive ophthalmic drug research and manufacturing enterprise”, and actively invests in the human eye health industry. The company is a professional ophthalmic drug R&D, production and sales enterprise with leading R&D technology level and wide product line coverage in China. The company's products include drugs to slow the progression of myopia in children, drugs to treat dry eye, ophthalmic anti-infective drugs, ophthalmic antiinflammatory/anti-infective drugs, eye dilators and ciliary muscle paralysis drugs, non-steroidal anti-inflammatory drugs, pupil reduction drugs, and anti-glaucoma drugs, etc., covering ten ophthalmic drug segments. The company has established a “full range and variety” ophthalmic drug product system. Corporate honors include: the State Intellectual Property Office recognized as a national intellectual property model enterprise, won the “9th Governor's Quality Award Silver Award of Liaoning Province”, “Liaoning May 1st Labor Award”, “2021-2023 Pharmaceutical Industry Law-abiding and Honest Enterprise”, “Provincial Green Factory”, 20th “National Quality Award”, “2023 Excellent Biochemical and Biological Enterprise Brand”, won the honorary title of Ophthalmology Science and Technology Progress, and the annual “Brand Enterprise List”, “The Most Popular Brand Enterprise List in Retail Pharmacies”, and the company's product Erming Sodium Hyaluronate Drops won the “Eye Health Store Recommendation Rate” The highest brand ” etc.

Company Profile

Short Name-A兴齐眼药
Symbol-A300573
Company NameShenyang Xingqi Pharmaceutical Co., Ltd.
Listing DateDec 8, 2016
Issue Price5.16
Shares Offered20.00M share(s)
FoundedMar 24, 1977
Legal Representativejidong liu
CEOe gao
Secretaryshaoyao zhang
Accounting FirmLixin Certified Public Accountants (Special General Partnership)
Securities Representativeshuo wang
Legal CounselBeijing Jingtian Gongcheng Law Firm
Employees1558
Phone024-22503989
Office Address30th Floor, Block B, Enterprise Plaza, 125 Qingnian Street, Shenhe District, Shenyang
Zip Code110016
Registered AddressNo. 25, Xinyunhe Road, Shenyang Area, China (Liaoning) Pilot Free Trade Zone
Fax024-22503987
Emailstock@sinqi.com
Business License210100401000628
BusinessLicensed projects: pharmaceutical production, health food production, disinfectant production (excluding dangerous chemicals), inspection and testing services, drug import and export (items subject to approval by law, business activities can only be carried out after approval by relevant departments; specific business projects are subject to approval results) General projects: plastic product manufacturing, non-residential real estate leasing, machinery and equipment leasing, goods import and export, technology import and export, technology services, technology development, technical consultation, technical exchange, technology transfer, technology promotion (except for projects subject to approval according to law, independent business activities are carried out according to law with a business license)

Company Executives

  • Name
  • Position
  • Salary
  • jidong liu
  • Chairman,directors
  • 6.00M
  • shaoyao zhang
  • Vice Chairman,directors,Board Secretary,Deputy General Manager
  • 2.08M
  • qiang yang
  • directors,Deputy General Manager
  • 1.32M
  • yanan cheng
  • directors,Deputy General Manager,Chief Financial Officer
  • 1.70M
  • e gao
  • directors,general manager
  • 2.08M
  • chunhua li
  • directors
  • 1.43M
  • xiaoyan kong
  • Independent directors
  • --
  • xianmei xu
  • Independent directors
  • --
  • xiaobin dai
  • Independent directors
  • 106.80K
  • shuo wang
  • Securities affairs representative
  • --
  • xiaoyu qu
  • Chairman of the Supervisory Board,auditors
  • 172.30K
  • bing li
  • auditors
  • 150.90K
  • fei ji
  • Employee supervisors
  • 164.30K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg